Published in Allergol Immunopathol (Madr) on September 25, 1981
Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi. Antimicrob Agents Chemother (1996) 5.27
Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect (2006) 2.67
Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol (2008) 2.57
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47
[The female sex and mortality after acute myocardial infarct]. Rev Esp Cardiol (1993) 2.44
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother (2013) 2.14
In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother (2001) 2.03
Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol (2009) 2.02
In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrob Chemother (1997) 2.02
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect (2014) 1.70
Emerging pathogens. Med Mycol (2000) 1.59
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. Int J Antimicrob Agents (2007) 1.57
Different virulence levels of the species of Sporothrix in a murine model. Clin Microbiol Infect (2009) 1.55
Antifungal susceptibilities of Paecilomyces species. Antimicrob Agents Chemother (1998) 1.54
Effects of incubation temperature, inoculum size, and time of reading on broth microdilution susceptibility test results for amphotericin B fgainst Fusarium. Antimicrob Agents Chemother (1997) 1.49
Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium. Stud Mycol (2011) 1.47
Use of mass spectrometry to identify clinical Fusarium isolates. Clin Microbiol Infect (2009) 1.46
A new species of Syspastospora from tropical soils. Mycologia (2010) 1.45
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother (2001) 1.44
Comments on recent human infections caused by ascomycetes. Med Mycol (1998) 1.43
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect (2014) 1.36
Spectrum of clinically relevant Acremonium species in the United States. J Clin Microbiol (2010) 1.35
Molecular characterization, relatedness and antifungal susceptibility of the basidiomycetous Hormographiella species and Coprinus cinereus from clinical and environmental sources. Antonie Van Leeuwenhoek (1996) 1.29
Phaeohyphomycotic cyst caused by Colletotrichum crassipes. J Clin Microbiol (2001) 1.29
Extended method for discrimination of Aeromonas spp. by 16S rDNA RFLP analysis. Int J Syst Evol Microbiol (2000) 1.28
Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol (1999) 1.24
Isolation and characterization of a new fungal species, Chrysosporium ophiodiicola, from a mycotic granuloma of a black rat snake (Elaphe obsoleta obsoleta). J Clin Microbiol (2008) 1.22
Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods. Antimicrob Agents Chemother (2000) 1.21
Distribution of virulence genes in clinical and environmental isolates of Aeromonas spp. Antonie Van Leeuwenhoek (2003) 1.19
Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immunosuppressed patients. J Clin Microbiol (2001) 1.18
Comparison of the virulence of Scedosporium prolificans strains from different origins in a murine model. J Med Microbiol (2002) 1.17
In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy (2001) 1.16
Type III secretion system genes in clinical Aeromonas isolates. J Clin Microbiol (2004) 1.16
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother (2014) 1.13
In vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungi. Antimicrob Agents Chemother (2001) 1.13
Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea. J Clin Microbiol (2010) 1.13
Alternaria infections: laboratory diagnosis and relevant clinical features. Clin Microbiol Infect (2008) 1.11
Viscoelastic-injecting cystotome. J Cataract Refract Surg (1998) 1.08
In vitro antifungal susceptibilities of Scopulariopsis isolates. Antimicrob Agents Chemother (1999) 1.08
Diversity of Bipolaris species in clinical samples in the United States and their antifungal susceptibility profiles. J Clin Microbiol (2012) 1.07
Phenotypic identification of Aeromonas genomospecies from clinical and environmental sources. Can J Microbiol (1998) 1.07
Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia. Eur J Clin Microbiol Infect Dis (1991) 1.05
Preconditioning: effect upon lesion modulation in warm liver ischemia. Transplant Proc (1993) 1.05
Biliary excretion as possible origin of Listeria monocytogenes in fecal carriers. Am J Vet Res (1992) 1.04
Molecular and phenotypic characterization of Phialemonium and Lecythophora isolates from clinical samples. J Clin Microbiol (2011) 1.03
Production of enterotoxin A by supposedly nonenterotoxigenic Staphylococcus aureus strains. Appl Environ Microbiol (1989) 1.03
Clinically relevant Aeromonas species. Clin Infect Dis (2000) 1.02
First record of the rare species Aeromonas culicicola from a drinking water supply. Appl Environ Microbiol (2005) 1.02
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob Agents Chemother (2012) 1.02
Prevalence of Salmonella serotypes in environmental waters and their relationships with indicator organisms. Antonie Van Leeuwenhoek (1999) 1.00
Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis. J Clin Microbiol (1997) 0.98
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method. Antimicrob Agents Chemother (2013) 0.96
Characterisation of Aeromonas spp. isolated from frozen fish intended for human consumption in Mexico. Int J Food Microbiol (2003) 0.96
Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes. J Clin Microbiol (2002) 0.95
Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis. Med Mycol (2010) 0.95
A case of disseminated mycosis in a German shepherd dog due to Penicillium purpurogenum. Med Mycol (2006) 0.95
Evaluation of two miniaturized systems, MicroScan W/A and BBL Crystal E/NF, for identification of clinical isolates of Aeromonas spp. J Clin Microbiol (2003) 0.95
A DNA probe specific for Aeromonas colonies. Diagn Microbiol Infect Dis (2002) 0.95
Sporothrix brunneoviolacea and Sporothrix dimorphospora, two new members of the Ophiostoma stenoceras-Sporothrix schenckii complex. Mycologia (2010) 0.94
Cutaneous phaeohyphomycosis caused by Caldosporium oxysporum and its treatment with potassium iodide. Med Mycol (2006) 0.92
Is "intra-operating room" thromboelastometry useful in liver transplantation? A case-control study in 303 patients. Transplant Proc (2013) 0.91
Experimental infection with Scedosporium inflatum. J Med Vet Mycol (1992) 0.91
Morphological changes in strains of Aspergillus flavus Link ex Fries and Aspergillus parasiticus Speare related with aflatoxin production. Mycopathologia (1980) 0.90
Case reports. Transient colonization with Scedosporium prolificans. Report of four cases in Madrid. Mycoses (2001) 0.90
Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus spp. J Antimicrob Chemother (2001) 0.89
Assessment of different selective agar media for enumeration and isolation of Listeria from dairy products. J Dairy Res (1988) 0.89
New findings in black piedra infection. Br J Dermatol (1996) 0.88
Growth of Staphylococcus aureus and synthesis of enterotoxin during ripening of experimental Manchego-type cheese. J Dairy Sci (1992) 0.88
Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading. Mycopathologia (1999) 0.88
Transformation of sterigmatocystin and O-methylsterigmatocystin by aflatoxigenic and nonaflatoxigenic field isolates of the Aspergillus flavus group. Mycopathologia (1991) 0.88
Virulence of Sporothrix luriei in a murine model of disseminated infection. Mycopathologia (2011) 0.87
[Two cases of scalp wound colonization and respiratory tract by mycelial fungi]. Rev Iberoam Micol (2000) 0.87
Experimental intramammary infection of ewes with Staphylococcus aureus subsp anaerobius. Res Vet Sci (1993) 0.87
Listeria monocytogenes CAMP reaction. Clin Microbiol Rev (1992) 0.87
In vitro antifungal susceptibility of Alternaria spp. and Ulocladium spp. J Antimicrob Chemother (2000) 0.87
Intraocular pressure as a risk factor for visual field loss in pseudoexfoliative and in primary open-angle glaucoma. Ophthalmology (1998) 0.87
Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection. J Clin Virol (2012) 0.87
Interlaboratory evaluation of the Etest for antifungal susceptibility testing of dermatophytes. Med Mycol (2003) 0.86
A rare case of chromoblastomycosis in a renal transplant recipient caused by a non-sporulating species of Rhytidhysteron. Med Mycol (2008) 0.86
Air-borne fungi in the air of Barcelona (Spain). IV. Various isolated genera. Mycopathologia (1980) 0.85
Effect of cervical spinal cord stimulation on regional blood flow and oxygenation in advanced head and neck tumours. Ann Oncol (2004) 0.85
Cutaneous phaeohyphomycosis caused by Alternaria longipes in an immunosuppressed patient. J Clin Microbiol (1995) 0.85
Liver transplantation in patients with cryptogenic cirrhosis: long-term follow-up. Transplant Proc (2011) 0.85
Increased susceptibility of microcytic red blood cells to in vitro oxidative stress. Eur J Haematol (1995) 0.84
Controversial data on the association of Aeromonas with diarrhoea in a recent Hong Kong study. J Med Microbiol (2007) 0.84
Endogenous endophthalmitis by Fusarium solani: an animal experimental model. Med Mycol (1998) 0.84
Fungal endocarditis in premature infants: case report and review. Clin Infect Dis (1996) 0.83
Detection of enterotoxins and TSST-1 secreted by Staphylococcus aureus isolated from ruminant mastitis. Comparison of ELISA and immunoblot. J Appl Bacteriol (1992) 0.83
Comparison of two methods for antifungal susceptibility testing of Trichophyton rubrum. Eur J Clin Microbiol Infect Dis (2002) 0.83
Hartmannella vermiformis isolated from the cerebrospinal fluid of a young male patient with meningoencephalitis and bronchopneumonia. Arch Med Res (1996) 0.83
Evaluation of the oxolinic acid--esculin--azide medium for the isolation and enumeration of faecal streptococci in a routine monitoring programme for bathing waters. Can J Microbiol (1998) 0.83
Results of liver transplantation with donors older than 70 years: a case-control study. Transplant Proc (2011) 0.82
Relationship between presence of Salmonella and indicators of faecal pollution in aquatic habitats. FEMS Microbiol Lett (1998) 0.82
Invasive mycotic infections caused by Chaetomium perlucidum, a new agent of cerebral phaeohyphomycosis. J Clin Microbiol (2003) 0.82
In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility. Chemotherapy (2003) 0.81
Use of restriction fragment length polymorphism of the PCR-amplified 16S rRNA gene for the identification of Aeromonas spp. J Clin Microbiol (2000) 0.81
Detection of staphylococcal enterotoxin and toxic shock syndrome toxin-1 (TSST-1) by immunoblot combined with a semiautomated electrophoresis system. J Immunol Methods (1991) 0.81